{"name":"OpGen","permalink":"opgen","crunchbase_url":"http://www.crunchbase.com/company/opgen","homepage_url":"http://www.opgen.com/","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":"biotech","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":"","alias_list":"","email_address":"","phone_number":"301.869.9683","description":"Optical Mapping","created_at":"Sat Dec 12 01:30:09 UTC 2009","updated_at":"Tue Mar 13 02:15:36 UTC 2012","overview":"<p>OpGen, Inc is a privately-held company, based in Gaithersburg, MD, and focused on commercializing rapid, high precision solutions for DNA analysis and genomics with the Argus® Whole Genome Mapping System and MapIt® Services. Using the proprietary technologies provided by OpGen, customers in academic, government, biodefense and research labs as well as premier genome centers around the world can view ordered whole genome maps for a wide range of applications including strain typing for early outbreak response, improved sequence assembly of microbial and now large genomes up to 3 Gb and comparative genomics applications.</p>\n\n<p>OpGen Community (Linkedin Group) provides an accessible environment to share information, exchange questions and best practices using OpGen’s technologies in a variety of applications.</p>","image":{"available_sizes":[[[150,39],"assets/images/resized/0006/9401/69401v2-max-150x150.png"],[[182,48],"assets/images/resized/0006/9401/69401v2-max-250x250.png"],[[182,48],"assets/images/resized/0006/9401/69401v2-max-450x450.png"]],"attribution":null},"products":[],"relationships":[{"is_past":false,"title":"Interim CEO","person":{"first_name":"Evan","last_name":"Jones","permalink":"evan-jones-3","image":null}},{"is_past":false,"title":"Chairman","person":{"first_name":"Ronald","last_name":"Lennox","permalink":"ronald-lennox","image":null}},{"is_past":false,"title":"Director","person":{"first_name":"Corey","last_name":"Mulloy","permalink":"corey-mulloy","image":{"available_sizes":[[[127,104],"assets/images/resized/0004/4596/44596v1-max-150x150.png"],[[127,104],"assets/images/resized/0004/4596/44596v1-max-250x250.png"],[[127,104],"assets/images/resized/0004/4596/44596v1-max-450x450.png"]],"attribution":""}}},{"is_past":false,"title":"Director","person":{"first_name":"Brian","last_name":"Atwood","permalink":"brian-atwood","image":null}},{"is_past":false,"title":"Director","person":{"first_name":"Bijan","last_name":"Salehizadeh, MD","permalink":"bijan-salehizadeh-md","image":{"available_sizes":[[[145,104],"assets/images/resized/0004/4598/44598v1-max-150x150.jpg"],[[145,104],"assets/images/resized/0004/4598/44598v1-max-250x250.jpg"],[[145,104],"assets/images/resized/0004/4598/44598v1-max-450x450.jpg"]],"attribution":""}}},{"is_past":false,"title":"Observer","person":{"first_name":"Trevor","last_name":"D'Souza","permalink":"trevor-dsouza","image":null}}],"competitions":[],"providerships":[],"total_money_raised":"$59.6M","funding_rounds":[{"round_code":"debt_round","source_url":"http://www.sec.gov/Archives/edgar/data/1293818/000129381809000004/xslFormDX01/primary_doc.xml","source_description":"SEC D","raised_amount":2000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":12,"funded_day":11,"investments":[]},{"round_code":"a","source_url":"http://opgen.com/NewsRoom/announcements.php?id=8","source_description":"OpGen Announces $23.6 Million Series A Financing","raised_amount":23600000,"raised_currency_code":"USD","funded_year":2007,"funded_month":9,"funded_day":12,"investments":[{"company":null,"financial_org":{"name":"CHL Medical Partners","permalink":"chl-medical-partners","image":{"available_sizes":[[[150,18],"assets/images/resized/0004/9271/49271v1-max-150x150.png"],[[250,31],"assets/images/resized/0004/9271/49271v1-max-250x250.png"],[[306,38],"assets/images/resized/0004/9271/49271v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Highland Capital Partners","permalink":"highland-capital-partners","image":{"available_sizes":[[[150,50],"assets/images/resized/0001/0992/10992v5-max-150x150.jpg"],[[200,67],"assets/images/resized/0001/0992/10992v5-max-250x250.jpg"],[[200,67],"assets/images/resized/0001/0992/10992v5-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Versant Ventures","permalink":"versant-ventures","image":{"available_sizes":[[[150,90],"assets/images/resized/0004/6455/46455v1-max-150x150.png"],[[161,97],"assets/images/resized/0004/6455/46455v1-max-250x250.png"],[[161,97],"assets/images/resized/0004/6455/46455v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Mason Wells Biomediacl Fund","permalink":"mason-wellsbiomediacl-fund","image":{"available_sizes":[[[150,40],"assets/images/resized/0010/2644/102644v1-max-150x150.png"],[[250,66],"assets/images/resized/0010/2644/102644v1-max-250x250.png"],[[371,99],"assets/images/resized/0010/2644/102644v1-max-450x450.png"]],"attribution":null}},"person":null}]},{"round_code":"b","source_url":"http://www.opgen.com/NewsRoom/announcements.php?id=13","source_description":"OpGen Completes $17 Million Series B Financing","raised_amount":17000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":9,"funded_day":28,"investments":[{"company":null,"financial_org":{"name":"jVen Capital","permalink":"jven-capital","image":null},"person":null},{"company":null,"financial_org":{"name":"CHL Medical Partners","permalink":"chl-medical-partners","image":{"available_sizes":[[[150,18],"assets/images/resized/0004/9271/49271v1-max-150x150.png"],[[250,31],"assets/images/resized/0004/9271/49271v1-max-250x250.png"],[[306,38],"assets/images/resized/0004/9271/49271v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Highland Capital Partners","permalink":"highland-capital-partners","image":{"available_sizes":[[[150,50],"assets/images/resized/0001/0992/10992v5-max-150x150.jpg"],[[200,67],"assets/images/resized/0001/0992/10992v5-max-250x250.jpg"],[[200,67],"assets/images/resized/0001/0992/10992v5-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Mason Wells Biomediacl Fund","permalink":"mason-wellsbiomediacl-fund","image":{"available_sizes":[[[150,40],"assets/images/resized/0010/2644/102644v1-max-150x150.png"],[[250,66],"assets/images/resized/0010/2644/102644v1-max-250x250.png"],[[371,99],"assets/images/resized/0010/2644/102644v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Versant Ventures","permalink":"versant-ventures","image":{"available_sizes":[[[150,90],"assets/images/resized/0004/6455/46455v1-max-150x150.png"],[[161,97],"assets/images/resized/0004/6455/46455v1-max-250x250.png"],[[161,97],"assets/images/resized/0004/6455/46455v1-max-450x450.png"]],"attribution":null}},"person":null}]},{"round_code":"unattributed","source_url":"http://www.finsmes.com/2012/03/opgen-receive-17m-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"OpGen to Receive up to $17M in Financing","raised_amount":17000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":3,"funded_day":7,"investments":[{"company":null,"financial_org":{"name":"Harris & Harris Group","permalink":"harris-harris-group","image":{"available_sizes":[[[150,120],"assets/images/resized/0003/2214/32214v1-max-150x150.jpg"],[[156,125],"assets/images/resized/0003/2214/32214v1-max-250x250.jpg"],[[156,125],"assets/images/resized/0003/2214/32214v1-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Cross Creek Capital","permalink":"cross-creek-capital","image":{"available_sizes":[[[150,77],"assets/images/resized/0004/6896/46896v1-max-150x150.jpg"],[[176,91],"assets/images/resized/0004/6896/46896v1-max-250x250.jpg"],[[176,91],"assets/images/resized/0004/6896/46896v1-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Highland Capital Partners","permalink":"highland-capital-partners","image":{"available_sizes":[[[150,50],"assets/images/resized/0001/0992/10992v5-max-150x150.jpg"],[[200,67],"assets/images/resized/0001/0992/10992v5-max-250x250.jpg"],[[200,67],"assets/images/resized/0001/0992/10992v5-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Versant Ventures","permalink":"versant-ventures","image":{"available_sizes":[[[150,90],"assets/images/resized/0004/6455/46455v1-max-150x150.png"],[[161,97],"assets/images/resized/0004/6455/46455v1-max-250x250.png"],[[161,97],"assets/images/resized/0004/6455/46455v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"jVen Capital","permalink":"jven-capital","image":null},"person":null},{"company":null,"financial_org":{"name":"CHL Medical Partners","permalink":"chl-medical-partners","image":{"available_sizes":[[[150,18],"assets/images/resized/0004/9271/49271v1-max-150x150.png"],[[250,31],"assets/images/resized/0004/9271/49271v1-max-250x250.png"],[[306,38],"assets/images/resized/0004/9271/49271v1-max-450x450.png"]],"attribution":null}},"person":null}]}],"investments":[{"funding_round":{"round_code":"unattributed","source_url":"http://www.masshightech.com/stories/2012/03/19/daily44-Connecticut-biotech-raises-256M-round.html","source_description":"Connecticut biotech raises $2.56M round","raised_amount":2560000,"raised_currency_code":"USD","funded_year":2012,"funded_month":3,"funded_day":22,"company":{"name":"BioRelix","permalink":"biorelix","image":{"available_sizes":[[[150,70],"assets/images/resized/0011/5274/115274v1-max-150x150.png"],[[155,73],"assets/images/resized/0011/5274/115274v1-max-250x250.png"],[[155,73],"assets/images/resized/0011/5274/115274v1-max-450x450.png"]],"attribution":null}}}}],"acquisition":null,"acquisitions":[],"offices":[{"description":"","address1":"708 Quince Orchard Road","address2":"","zip_code":"20878","city":"Gaithersburg","state_code":"MD","country_code":"USA","latitude":null,"longitude":null}],"milestones":[{"description":"OpGen Topping Off Series B Round For DNA-Analysis Instrument Sales ","stoned_year":2011,"stoned_month":2,"stoned_day":9,"source_url":"https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=29&aid=DJFVLS0020110209e7290005l&r=Rss&s=DJFVLS","source_text":"","source_description":"OpGen Topping Off Series B Round For DNA-Analysis Instrument Sales ","stoneable_type":"Company","stoned_value":null,"stoned_value_type":null,"stoned_acquirer":null,"stoneable":{"name":"OpGen","permalink":"opgen"}}],"ipo":null,"video_embeds":[],"screenshots":[{"available_sizes":[[[150,89],"assets/images/resized/0008/0093/80093v1-max-150x150.jpg"],[[250,149],"assets/images/resized/0008/0093/80093v1-max-250x250.jpg"],[[450,268],"assets/images/resized/0008/0093/80093v1-max-450x450.jpg"]],"attribution":null}],"external_links":[{"external_url":"http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001293818","title":"SEC"}]}